Generate a tailored SOP for Dr. Robert Lafyatis. Improve your application with a focused, well-structured draft.
Robert Lafyatis is an Adjunct Professor in the Chobanian & Avedisian School of Medicine at Boston University, where he specializes in Rheumatology. He holds an MD from the University of Cincinnati and a BS from the Massachusetts Institute of Technology. Dr. Lafyatis's research primarily focuses on systemic sclerosis, particularly the treatment and identification of biomarkers in this condition. He is actively involved in early phase clinical trials which evaluate new therapeutic agents for patients suffering from systemic sclerosis and has worked on investigating mechanisms and markers related to the response to novel therapeutics including B cell depleting agents like rituximab and immunosuppressive agents like mycophenolate. His ongoing studies utilize microarray gene expression analysis to identify biomarkers in skin and blood samples of scleroderma patients. Additionally, Dr. Lafyatis is researching the molecular underpinnings of pulmonary hypertension in systemic sclerosis and the cause of fibrosis and vascular damage linked to the disease. He is a member of the Boston University Evans Center for Interdisciplinary Biomedical Research and actively participates in various research initiatives. His contributions to the understanding of systemic sclerosis have significant implications for future treatment strategies.
Department of Law offers JD, LLM, and Master's in Study of Tax Law.